InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) released preliminary financial results for the third quarter of 2022, revealing record revenue estimated to be CA$39 million, 63% over the revenues of the third quarter of 2021 and sequential growth of over 6%.

Preliminary Q3 2022 Financial Highlights and Milestones

Full story available on Benzinga.com